Liposarcoma Treatment Market - Global Outlook and Forecast 2022-2028

March 2022 | 107 pages | ID: LC9FE217CB35EN
Market Monitor Global

Abstracts

Liposarcoma is a cancer of fat cells lying deep within the soft tissues, typically in retroperitoneum or thighs.

This report contains market size and forecasts of Liposarcoma Treatment in Global, including the following market information:

Global Liposarcoma Treatment Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global top five companies in 2021 (%)

The global Liposarcoma Treatment market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Chemothersapy Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Liposarcoma Treatment include Johnson & Johnson, Pfizer, Eli Lilly, Sanofi SA, Novartis AG, Baxter International, Bristol Laboratories, Teva Pharmaceutical Industries and Mylan N.V, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Liposarcoma Treatment companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Liposarcoma Treatment Market, by Type, 2017-2022, 2023-2028 ($ millions)

Global Liposarcoma Treatment Market Segment Percentages, by Type, 2021 (%)

• Chemothersapy
• Radiation Therapy
• Surgical Therapy

Global Liposarcoma Treatment Market, by Application, 2017-2022, 2023-2028 ($ millions)

Global Liposarcoma Treatment Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Multispecialty Clinics
• Cancer Treatment and Rehabilitation Centers
• Others

Global Liposarcoma Treatment Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)

Global Liposarcoma Treatment Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Liposarcoma Treatment revenues in global market, 2017-2022 (estimated), ($ millions)

Key companies Liposarcoma Treatment revenues share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Johnson & Johnson
• Pfizer
• Eli Lilly
• Sanofi SA
• Novartis AG
• Baxter International
• Bristol Laboratories
• Teva Pharmaceutical Industries
• Mylan N.V
• Actavis
• Fresenius Kabi
• Accord Healthcare
• Taro Pharmaceuticals
• Sandoz
• Bedford Laboratories

Contents

1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Liposarcoma Treatment Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Liposarcoma Treatment Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL LIPOSARCOMA TREATMENT OVERALL MARKET SIZE

2.1 Global Liposarcoma Treatment Market Size: 2021 VS 2028
2.2 Global Liposarcoma Treatment Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Liposarcoma Treatment Players in Global Market
3.2 Top Global Liposarcoma Treatment Companies Ranked by Revenue
3.3 Global Liposarcoma Treatment Revenue by Companies
3.4 Top 3 and Top 5 Liposarcoma Treatment Companies in Global Market, by Revenue in 2021
3.5 Global Companies Liposarcoma Treatment Product Type
3.6 Tier 1, Tier 2 and Tier 3 Liposarcoma Treatment Players in Global Market
  3.6.1 List of Global Tier 1 Liposarcoma Treatment Companies
  3.6.2 List of Global Tier 2 and Tier 3 Liposarcoma Treatment Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 by Type - Global Liposarcoma Treatment Market Size Markets, 2021 & 2028
  4.1.2 Chemothersapy
  4.1.3 Radiation Therapy
  4.1.4 Surgical Therapy
4.2 By Type - Global Liposarcoma Treatment Revenue & Forecasts
  4.2.1 By Type - Global Liposarcoma Treatment Revenue, 2017-2022
  4.2.2 By Type - Global Liposarcoma Treatment Revenue, 2023-2028
  4.2.3 By Type - Global Liposarcoma Treatment Revenue Market Share, 2017-2028

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Liposarcoma Treatment Market Size, 2021 & 2028
  5.1.2 Hospitals
  5.1.3 Multispecialty Clinics
  5.1.4 Cancer Treatment and Rehabilitation Centers
  5.1.5 Others
5.2 By Application - Global Liposarcoma Treatment Revenue & Forecasts
  5.2.1 By Application - Global Liposarcoma Treatment Revenue, 2017-2022
  5.2.2 By Application - Global Liposarcoma Treatment Revenue, 2023-2028
  5.2.3 By Application - Global Liposarcoma Treatment Revenue Market Share, 2017-2028

6 SIGHTS BY REGION

6.1 By Region - Global Liposarcoma Treatment Market Size, 2021 & 2028
6.2 By Region - Global Liposarcoma Treatment Revenue & Forecasts
  6.2.1 By Region - Global Liposarcoma Treatment Revenue, 2017-2022
  6.2.2 By Region - Global Liposarcoma Treatment Revenue, 2023-2028
  6.2.3 By Region - Global Liposarcoma Treatment Revenue Market Share, 2017-2028
6.3 North America
  6.3.1 By Country - North America Liposarcoma Treatment Revenue, 2017-2028
  6.3.2 US Liposarcoma Treatment Market Size, 2017-2028
  6.3.3 Canada Liposarcoma Treatment Market Size, 2017-2028
  6.3.4 Mexico Liposarcoma Treatment Market Size, 2017-2028
6.4 Europe
  6.4.1 By Country - Europe Liposarcoma Treatment Revenue, 2017-2028
  6.4.2 Germany Liposarcoma Treatment Market Size, 2017-2028
  6.4.3 France Liposarcoma Treatment Market Size, 2017-2028
  6.4.4 U.K. Liposarcoma Treatment Market Size, 2017-2028
  6.4.5 Italy Liposarcoma Treatment Market Size, 2017-2028
  6.4.6 Russia Liposarcoma Treatment Market Size, 2017-2028
  6.4.7 Nordic Countries Liposarcoma Treatment Market Size, 2017-2028
  6.4.8 Benelux Liposarcoma Treatment Market Size, 2017-2028
6.5 Asia
  6.5.1 By Region - Asia Liposarcoma Treatment Revenue, 2017-2028
  6.5.2 China Liposarcoma Treatment Market Size, 2017-2028
  6.5.3 Japan Liposarcoma Treatment Market Size, 2017-2028
  6.5.4 South Korea Liposarcoma Treatment Market Size, 2017-2028
  6.5.5 Southeast Asia Liposarcoma Treatment Market Size, 2017-2028
  6.5.6 India Liposarcoma Treatment Market Size, 2017-2028
6.6 South America
  6.6.1 By Country - South America Liposarcoma Treatment Revenue, 2017-2028
  6.6.2 Brazil Liposarcoma Treatment Market Size, 2017-2028
  6.6.3 Argentina Liposarcoma Treatment Market Size, 2017-2028
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Liposarcoma Treatment Revenue, 2017-2028
  6.7.2 Turkey Liposarcoma Treatment Market Size, 2017-2028
  6.7.3 Israel Liposarcoma Treatment Market Size, 2017-2028
  6.7.4 Saudi Arabia Liposarcoma Treatment Market Size, 2017-2028
  6.7.5 UAE Liposarcoma Treatment Market Size, 2017-2028

7 PLAYERS PROFILES

7.1 Johnson & Johnson
  7.1.1 Johnson & Johnson Corporate Summary
  7.1.2 Johnson & Johnson Business Overview
  7.1.3 Johnson & Johnson Liposarcoma Treatment Major Product Offerings
  7.1.4 Johnson & Johnson Liposarcoma Treatment Revenue in Global Market (2017-2022)
  7.1.5 Johnson & Johnson Key News
7.2 Pfizer
  7.2.1 Pfizer Corporate Summary
  7.2.2 Pfizer Business Overview
  7.2.3 Pfizer Liposarcoma Treatment Major Product Offerings
  7.2.4 Pfizer Liposarcoma Treatment Revenue in Global Market (2017-2022)
  7.2.5 Pfizer Key News
7.3 Eli Lilly
  7.3.1 Eli Lilly Corporate Summary
  7.3.2 Eli Lilly Business Overview
  7.3.3 Eli Lilly Liposarcoma Treatment Major Product Offerings
  7.3.4 Eli Lilly Liposarcoma Treatment Revenue in Global Market (2017-2022)
  7.3.5 Eli Lilly Key News
7.4 Sanofi SA
  7.4.1 Sanofi SA Corporate Summary
  7.4.2 Sanofi SA Business Overview
  7.4.3 Sanofi SA Liposarcoma Treatment Major Product Offerings
  7.4.4 Sanofi SA Liposarcoma Treatment Revenue in Global Market (2017-2022)
  7.4.5 Sanofi SA Key News
7.5 Novartis AG
  7.5.1 Novartis AG Corporate Summary
  7.5.2 Novartis AG Business Overview
  7.5.3 Novartis AG Liposarcoma Treatment Major Product Offerings
  7.5.4 Novartis AG Liposarcoma Treatment Revenue in Global Market (2017-2022)
  7.5.5 Novartis AG Key News
7.6 Baxter International
  7.6.1 Baxter International Corporate Summary
  7.6.2 Baxter International Business Overview
  7.6.3 Baxter International Liposarcoma Treatment Major Product Offerings
  7.6.4 Baxter International Liposarcoma Treatment Revenue in Global Market (2017-2022)
  7.6.5 Baxter International Key News
7.7 Bristol Laboratories
  7.7.1 Bristol Laboratories Corporate Summary
  7.7.2 Bristol Laboratories Business Overview
  7.7.3 Bristol Laboratories Liposarcoma Treatment Major Product Offerings
  7.7.4 Bristol Laboratories Liposarcoma Treatment Revenue in Global Market (2017-2022)
  7.7.5 Bristol Laboratories Key News
7.8 Teva Pharmaceutical Industries
  7.8.1 Teva Pharmaceutical Industries Corporate Summary
  7.8.2 Teva Pharmaceutical Industries Business Overview
  7.8.3 Teva Pharmaceutical Industries Liposarcoma Treatment Major Product Offerings
  7.8.4 Teva Pharmaceutical Industries Liposarcoma Treatment Revenue in Global Market (2017-2022)
  7.8.5 Teva Pharmaceutical Industries Key News
7.9 Mylan N.V
  7.9.1 Mylan N.V Corporate Summary
  7.9.2 Mylan N.V Business Overview
  7.9.3 Mylan N.V Liposarcoma Treatment Major Product Offerings
  7.9.4 Mylan N.V Liposarcoma Treatment Revenue in Global Market (2017-2022)
  7.9.5 Mylan N.V Key News
7.10 Actavis
  7.10.1 Actavis Corporate Summary
  7.10.2 Actavis Business Overview
  7.10.3 Actavis Liposarcoma Treatment Major Product Offerings
  7.10.4 Actavis Liposarcoma Treatment Revenue in Global Market (2017-2022)
  7.10.5 Actavis Key News
7.11 Fresenius Kabi
  7.11.1 Fresenius Kabi Corporate Summary
  7.11.2 Fresenius Kabi Business Overview
  7.11.3 Fresenius Kabi Liposarcoma Treatment Major Product Offerings
  7.11.4 Fresenius Kabi Liposarcoma Treatment Revenue in Global Market (2017-2022)
  7.11.5 Fresenius Kabi Key News
7.12 Accord Healthcare
  7.12.1 Accord Healthcare Corporate Summary
  7.12.2 Accord Healthcare Business Overview
  7.12.3 Accord Healthcare Liposarcoma Treatment Major Product Offerings
  7.12.4 Accord Healthcare Liposarcoma Treatment Revenue in Global Market (2017-2022)
  7.12.5 Accord Healthcare Key News
7.13 Taro Pharmaceuticals
  7.13.1 Taro Pharmaceuticals Corporate Summary
  7.13.2 Taro Pharmaceuticals Business Overview
  7.13.3 Taro Pharmaceuticals Liposarcoma Treatment Major Product Offerings
  7.13.4 Taro Pharmaceuticals Liposarcoma Treatment Revenue in Global Market (2017-2022)
  7.13.5 Taro Pharmaceuticals Key News
7.14 Sandoz
  7.14.1 Sandoz Corporate Summary
  7.14.2 Sandoz Business Overview
  7.14.3 Sandoz Liposarcoma Treatment Major Product Offerings
  7.14.4 Sandoz Liposarcoma Treatment Revenue in Global Market (2017-2022)
  7.14.5 Sandoz Key News
7.15 Bedford Laboratories
  7.15.1 Bedford Laboratories Corporate Summary
  7.15.2 Bedford Laboratories Business Overview
  7.15.3 Bedford Laboratories Liposarcoma Treatment Major Product Offerings
  7.15.4 Bedford Laboratories Liposarcoma Treatment Revenue in Global Market (2017-2022)
  7.15.5 Bedford Laboratories Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer

List Of Tables

LIST OF TABLES

Table 1. Liposarcoma Treatment Market Opportunities & Trends in Global Market
Table 2. Liposarcoma Treatment Market Drivers in Global Market
Table 3. Liposarcoma Treatment Market Restraints in Global Market
Table 4. Key Players of Liposarcoma Treatment in Global Market
Table 5. Top Liposarcoma Treatment Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Liposarcoma Treatment Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Liposarcoma Treatment Revenue Share by Companies, 2017-2022
Table 8. Global Companies Liposarcoma Treatment Product Type
Table 9. List of Global Tier 1 Liposarcoma Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Liposarcoma Treatment Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Liposarcoma Treatment Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Liposarcoma Treatment Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Liposarcoma Treatment Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Liposarcoma Treatment Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Liposarcoma Treatment Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Liposarcoma Treatment Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Liposarcoma Treatment Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Liposarcoma Treatment Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Liposarcoma Treatment Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Liposarcoma Treatment Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Liposarcoma Treatment Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Liposarcoma Treatment Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Liposarcoma Treatment Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Liposarcoma Treatment Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Liposarcoma Treatment Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Liposarcoma Treatment Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Liposarcoma Treatment Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Liposarcoma Treatment Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Liposarcoma Treatment Revenue, (US$, Mn), 2023-2028
Table 30. Johnson & Johnson Corporate Summary
Table 31. Johnson & Johnson Liposarcoma Treatment Product Offerings
Table 32. Johnson & Johnson Liposarcoma Treatment Revenue (US$, Mn), (2017-2022)
Table 33. Pfizer Corporate Summary
Table 34. Pfizer Liposarcoma Treatment Product Offerings
Table 35. Pfizer Liposarcoma Treatment Revenue (US$, Mn), (2017-2022)
Table 36. Eli Lilly Corporate Summary
Table 37. Eli Lilly Liposarcoma Treatment Product Offerings
Table 38. Eli Lilly Liposarcoma Treatment Revenue (US$, Mn), (2017-2022)
Table 39. Sanofi SA Corporate Summary
Table 40. Sanofi SA Liposarcoma Treatment Product Offerings
Table 41. Sanofi SA Liposarcoma Treatment Revenue (US$, Mn), (2017-2022)
Table 42. Novartis AG Corporate Summary
Table 43. Novartis AG Liposarcoma Treatment Product Offerings
Table 44. Novartis AG Liposarcoma Treatment Revenue (US$, Mn), (2017-2022)
Table 45. Baxter International Corporate Summary
Table 46. Baxter International Liposarcoma Treatment Product Offerings
Table 47. Baxter International Liposarcoma Treatment Revenue (US$, Mn), (2017-2022)
Table 48. Bristol Laboratories Corporate Summary
Table 49. Bristol Laboratories Liposarcoma Treatment Product Offerings
Table 50. Bristol Laboratories Liposarcoma Treatment Revenue (US$, Mn), (2017-2022)
Table 51. Teva Pharmaceutical Industries Corporate Summary
Table 52. Teva Pharmaceutical Industries Liposarcoma Treatment Product Offerings
Table 53. Teva Pharmaceutical Industries Liposarcoma Treatment Revenue (US$, Mn), (2017-2022)
Table 54. Mylan N.V Corporate Summary
Table 55. Mylan N.V Liposarcoma Treatment Product Offerings
Table 56. Mylan N.V Liposarcoma Treatment Revenue (US$, Mn), (2017-2022)
Table 57. Actavis Corporate Summary
Table 58. Actavis Liposarcoma Treatment Product Offerings
Table 59. Actavis Liposarcoma Treatment Revenue (US$, Mn), (2017-2022)
Table 60. Fresenius Kabi Corporate Summary
Table 61. Fresenius Kabi Liposarcoma Treatment Product Offerings
Table 62. Fresenius Kabi Liposarcoma Treatment Revenue (US$, Mn), (2017-2022)
Table 63. Accord Healthcare Corporate Summary
Table 64. Accord Healthcare Liposarcoma Treatment Product Offerings
Table 65. Accord Healthcare Liposarcoma Treatment Revenue (US$, Mn), (2017-2022)
Table 66. Taro Pharmaceuticals Corporate Summary
Table 67. Taro Pharmaceuticals Liposarcoma Treatment Product Offerings
Table 68. Taro Pharmaceuticals Liposarcoma Treatment Revenue (US$, Mn), (2017-2022)
Table 69. Sandoz Corporate Summary
Table 70. Sandoz Liposarcoma Treatment Product Offerings
Table 71. Sandoz Liposarcoma Treatment Revenue (US$, Mn), (2017-2022)
Table 72. Bedford Laboratories Corporate Summary
Table 73. Bedford Laboratories Liposarcoma Treatment Product Offerings
Table 74. Bedford Laboratories Liposarcoma Treatment Revenue (US$, Mn), (2017-2022)

List Of Figures

LIST OF FIGURES

Figure 1. Liposarcoma Treatment Segment by Type in 2021
Figure 2. Liposarcoma Treatment Segment by Application in 2021
Figure 3. Global Liposarcoma Treatment Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global Liposarcoma Treatment Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Liposarcoma Treatment Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Liposarcoma Treatment Revenue in 2021
Figure 8. By Type - Global Liposarcoma Treatment Revenue Market Share, 2017-2028
Figure 9. By Application - Global Liposarcoma Treatment Revenue Market Share, 2017-2028
Figure 10. By Region - Global Liposarcoma Treatment Revenue Market Share, 2017-2028
Figure 11. By Country - North America Liposarcoma Treatment Revenue Market Share, 2017-2028
Figure 12. US Liposarcoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Liposarcoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Liposarcoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Liposarcoma Treatment Revenue Market Share, 2017-2028
Figure 16. Germany Liposarcoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 17. France Liposarcoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Liposarcoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Liposarcoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Liposarcoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Liposarcoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Liposarcoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Liposarcoma Treatment Revenue Market Share, 2017-2028
Figure 24. China Liposarcoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Liposarcoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Liposarcoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Liposarcoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 28. India Liposarcoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Liposarcoma Treatment Revenue Market Share, 2017-2028
Figure 30. Brazil Liposarcoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Liposarcoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Liposarcoma Treatment Revenue Market Share, 2017-2028
Figure 33. Turkey Liposarcoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Liposarcoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Liposarcoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Liposarcoma Treatment Revenue, (US$, Mn), 2017-2028
Figure 37. Johnson & Johnson Liposarcoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Pfizer Liposarcoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Eli Lilly Liposarcoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Sanofi SA Liposarcoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Novartis AG Liposarcoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Baxter International Liposarcoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Bristol Laboratories Liposarcoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. Teva Pharmaceutical Industries Liposarcoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Mylan N.V Liposarcoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Actavis Liposarcoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Fresenius Kabi Liposarcoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Accord Healthcare Liposarcoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 49. Taro Pharmaceuticals Liposarcoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 50. Sandoz Liposarcoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 51. Bedford Laboratories Liposarcoma Treatment Revenue Year Over Year Growth (US$, Mn) & (2017-2022)